PharPoint's senior management team

Members of our leadership team hold an average of 21 years experience in clinical research. Together with PharPoint’s founders, they lead our teams in anticipating challenges, providing quality solutions, and staying ahead of clinical trial deadlines.

Jayme Swinson Jayme Swinson, MS
Executive Director of Operations

Jayme Swinson’s experience in the CRO industry includes both statistical analysis and clinical database programming support for Phase 1 to Phase 4 clinical trials as well as patient registries.

He’s led multiple data standardization and warehousing projects, many of which comply with the industry-accepted SDTM format.

Mr. Swinson was one of the original members at PharPoint, and established and led the programming department, defining and refining standard processes across functional areas.

Amy Flynt Amy Flynt, PhD
Executive Director of Biostatistics and Statistical Programming

Amy Flynt, PhD, joined PharPoint in its inaugural year to grow biostatistics operations.

Prior to PharPoint, her experience includes having provided FDA representation, serving as a DMC statistician, and acting as a statistical consultant.

She’s served as a lead statistician and provided statistical support for Phase 1 through 4 clinical trials, NDA submissions, and industry-sponsored registries.

Moya Hawkins Moya Hawkins
Senior Director, Biometrics Strategy

Moya Hawkins has experience managing Phase 1 through Phase 4 clinical trials across both EDC and paper platforms, including global, multilingual Phase 3 and 4 studies.

Her database experience includes serving on EDC steering committees within several companies, application validation, and serving as a point person for the implementation of the transition from paper-based studies to EDC studies.

Ms. Hawkins has experience managing multi-country, emergency use protocol studies with special patient populations, and salvage therapy studies. She has served on a committee for the Society of Clinical Data Management, a non-profit dedicated to the advancement of clinical data management.

Stacey Smith Will, CCRA Stacey Smith Will, CCRA
Senior Director, Clinical Operations

Stacey Smith Will, CCRA, has 28 years of experience in clinical research with a diverse therapeutic background including infectious disease, vaccines, rare disease, autoimmune disorders, oncology, endocrinology, and gastroenterology.

Throughout her career, Ms. Will has trained, led, and engaged high-performing organizational teams, with particular focus within clinical monitoring and site management.

Prior to joining PharPoint, Ms. Will served as Director of Clinical Leads at a large global CRO. She also held leadership positions for North American Regional R&D Solutions Operations, North American Clinical FSP, and Clinical Site Management, among other roles.

Paul Johnson Paul Johnson
Senior Director, Clinical Strategy

Paul Johnson’s experience includes both working in healthcare as well as in the drug development. Mr. Johnson brings extensive experience as a CRA, clinical project manager and clinical operations manager.

Throughout his career, he has developed and implemented various project management methodologies. This has included study planning, risk management and contingency plans as well as managing the execution of site monitoring, site management, and data collection.

In his previous management roles, Mr. Johnson has recommended and implemented various clinical operations performance and productivity improvements and consistently ensuring sponsor expectations were met.

Ann Trace Ann Trace, ME
Director, Quality Assurance

Ann Trace, Director of Quality Assurance, brings 12 years of experience in clinical research to PharPoint, with a track record of success within the CRO environment.

Ms. Trace joined PharPoint from an oncology, infectious disease, and neurology CRO, where she managed QA and Training departments and oversaw the QA audit program. Throughout her career, Ms. Trace has provided quality oversight, regulatory consulting, guidance and compliance support for Phase 1 to Phase 4 clinical trials.

Ms. Trace is a member of the North Carolina Chapter Society of Quality Assurance and has her Master of Engineering in Biomedical Engineering from the University of Virginia.

Baker Sharpe Baker Sharpe
Director, Data Management

Baker Sharpe holds 13+ years of experience in clinical data management, spanning therapeutic areas including infectious disease, oncology, cardiovascular, and numerous others.

Before joining PharPoint, Ms. Sharpe spent 9 years in roles of increasing responsibility in the data management departments of two large CROs.

Currently, along with ensuring optimal performance of PharPoint’s data management group functions, Ms. Sharpe has worked to continuously train and develop the data management team to increase efficiencies and maintain state-of-the-art data management practices.

Karisa Satterly Karisa Satterly
Director of Business Development

As PharPoint’s Director of Business Development, Karisa Satterly leads initiatives for company growth and helps diversify PharPoint’s pipeline of work. She brings over a decade of experience in the industry to PharPoint.

Ms. Satterly’s experience in clinical research includes working across the biotech, pharma, device, and CRO industries. Prior to PharPoint, Ms. Satterly held various roles of increasing responsibility in the data management industry, including positions in business analytics, marketing, business development, and account management.

Ms. Satterly holds a Bachelors of Business Administration from Texas A&M University. To speak with a representative on PharPoint’s business development team, visit our “Contact Us” page or email us at bizdev@pharpoint.com.


Team Experience Overview →

Mission & Values →

Company Founders →